Aoxin Q&M Overhauls Board Line-Up, Seeks New Independent Directors

Aoxin Q&M Dental Group Ltd. ( (SG:1D4) ) has shared an update.

Aoxin Q&M Dental Group has reconstituted its board and key board committees following recent changes in directorship, including the appointment of Mr. Tan Chade Phang as Lead Independent Director and the redesignation of Mr. Chua Ser Miang as Non-Executive and Non-Independent Chairman. The Audit, Remuneration and Nominating Committees have been refreshed with new compositions, while the company has started searching for additional independent directors to restore a balanced mix of skills and independence and aims to fill these vacancies within two to three months in line with Catalist governance requirements.

These governance changes are intended to strengthen oversight and decision-making at the board level after the departure of two independent directors, reflecting the group’s effort to maintain regulatory compliance and robust corporate governance standards. For stakeholders, the reconstitution signals continuity and an ongoing commitment to board independence and diversity of expertise, which could support investor confidence and the company’s long-term strategic execution in the dental healthcare market.

More about Aoxin Q&M Dental Group Ltd.

Aoxin Q&M Dental Group Ltd., incorporated in Singapore, operates in the dental healthcare sector through a network of clinics and related services. The group focuses on providing dental treatment and oral healthcare solutions, positioning itself as a regional player in the medical and dental services market.

Average Trading Volume: 14,618,855

Technical Sentiment Signal: Buy

Current Market Cap: S$201.5M

For detailed information about 1D4 stock, go to TipRanks’ Stock Analysis page.